Maxygen, Inc. (NASDAQ:MAXY)
Industry: Services

Maxygen, Inc., a biopharmaceutical company, engages in developing various products in the field of human therapeutics in North America. It focuses on the development of MAXY-G34 product candidate, a granulocyte colony stimulating factor, for the treatment of chemotherapy-induced neutropenia and acute radiation syndrome. The company was founded in 1996 and is headquartered in San Mateo, California.

Current Quote*
Last: $2.530
Change: 0.000
Book: $0.800
Volume: 19,177

As Of: 02/11 15:58 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol MAXY

  • No BuyIns.Net Alerts Available for MAXY

Graphs for MAXY


3 Month Graph


6 Month Graph


1 Year Graph